Fortress Biotech, Inc. (FBIO) vs Gossamer Bio, Inc. (GOSS)
A side-by-side comparison of Fortress Biotech, Inc. and Gossamer Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBIO
Fortress Biotech, Inc.
$2.07HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
GOSS
Gossamer Bio, Inc.
$10.61HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — FBIO vs GOSS
growth of $100 · dividends reinvested · last 8yFBIO -93.5% (-28.9%/yr)GOSS -99.3% (-45.8%/yr)FBIO compounded faster over this window
Log scale — wide-divergence pair
FBIO GOSS
FBIO vs GOSS: by the numbers
- •FBIO is the larger company ($69M vs $65M market cap).
- •FBIO is profitable (163.32% net margin) while GOSS runs a net loss (-235.00%).
Metrics side by side
Valuation
| Metric | FBIO | GOSS |
|---|---|---|
| P/E ratio | 0.77 | N/A |
| P/S ratio | 1.00 | 1.22 |
| P/B ratio | 0.42 | N/A |
| FCF yield | 183.45% | N/A |
Profitability
| Metric | FBIO | GOSS |
|---|---|---|
| Gross margin | 62.53% | 99.56% |
| Operating margin | -111.00% | -336.81% |
| Net margin | 163.32% | -235.00% |
| ROE | 68.12% | N/A |
| ROIC | -10.85% | N/A |
Growth (annualized)
| Metric | FBIO | GOSS |
|---|---|---|
| Revenue CAGR (5Y) | 5.39% | N/A |
| Total return CAGR (5Y) | -46.06% | -59.51% |
Frequently asked
- Is FBIO or GOSS more profitable?
- FBIO runs the higher net margin — FBIO at 163.32% versus GOSS at -235.00%.
- How have FBIO and GOSS total returns compared?
- Over the past 5 years, FBIO delivered -46.06% and GOSS delivered -59.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioFortress Biotech ROEGossamer Bio ROEFortress Biotech operating marginGossamer Bio operating marginFortress Biotech revenue growthGossamer Bio revenue growthFortress Biotech free cash flowGossamer Bio free cash flow
Fortress Biotech & Gossamer Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.